DEXLIFE presentations at EASD 2014
At the EASD meeting in Vienna last week, researchers from DEXLIFE presented the latest data. An array of quantitative assays for 23 metabolites associated with prediabetes and diabetes was developed by Metabolon. At the DCU, they have showed that of the 23 metabolites, 11 changed following a 12-week lifestyle intervention in prediabetics. This suggests that these 11 metabolites can monitor the efficacy of a lifestyle intervention.
Dr. Aileen Kennedy from DCU
Dr. Jeff Cobb from Metabolon